The procurement consists of both dental and intravenous types of the medication Radicava.
发布者：BY ALBERT RONNING-ANDERSSON，转转请注明出处：https://robotalks.cn/japanese-drugmaker-acquires-one-of-the-few-approved-als-drugs-for-usd-2-5bn/
Japanese drugmaker acquires one of the few approved ALS drugs for USD 2.5bn
赞 (0)
关于作者
Tablet approval is “an early Christmas present for Novo Nordisk shareholders,” analysts say
上一篇
25 12 月, 2025 10:18 下午
Novo Nordisk ventures into uncharted territory with Wegovy pill: “We have never launched in this way before”
下一篇
25 12 月, 2025 10:18 下午
相关推荐
-
AI video becomes more convincing, rattling creative industry
Gone are the days of six-fingered hands or altered faces– AI-generated video clip is coming to be significantly persuading, bring in Hollywood, musicians, and marketers, whil…
-
Global collaborative robot market forecast to grow 12 percent a year to 2031
The worldwide Collaborative Robotic (Cobot) Sales Market, valued at $1,020 million in 2024, is forecasted to get to $2,199 million by 2031, expanding at a compound yearly developme…
-
Cornell transforms generative AI education (with help from a cloned professor)
Designing and Constructing AI Options is a brand new on-line certificates program, with one-of-a-kind options designed to reinforce the educational expertise for those who want to …
-
Equinox Gold to buy Calibre for $1.8B
Equinox Gold (TSX: EQX) (NYSE American: EQX) has agreed to acquire Calibre Mining (TSX: CXB) in a C$ 2.6 billion ($ 1.8 billion) all-stock offer that would certainly make the mixed…
-
Why brands and agencies are putting AI chiefs in their C-Suites
Senior roles for AI bosses are becoming more common at advertisers and agencies. Some face internally and others are external evangelizers…Read More
